Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations.


Journal

Cancer cytopathology
ISSN: 1934-6638
Titre abrégé: Cancer Cytopathol
Pays: United States
ID NLM: 101499453

Informations de publication

Date de publication:
01 2021
Historique:
received: 22 05 2020
revised: 11 07 2020
accepted: 22 07 2020
pubmed: 3 9 2020
medline: 27 7 2021
entrez: 3 9 2020
Statut: ppublish

Résumé

NUT carcinoma (NC) is an aggressive neoplasm that often presents with alarge tumor burden and metastases; cytology is frequently one of the primary diagnostic modalities. Primary pulmonary NCs are very rare and cytology descriptions are limited. The current study was performed to analyze the cytomorphological features of primary pulmonary NCs in different cytology samples and preparations. A total of 15 cytology specimens from 10 patients with primary pulmonary NCs diagnosed primarily on histology were retrieved and reviewed. Fifteen cytology samples, including aspirates from primary (5 samples) and metastatic (5 samples) sites, sputum (1 sample), and effusions (4 samples), that were prepared as direct smears, centrifuged smears, and cell blocks were reviewed. Aspirate smears from all cases were cellular and demonstrated fragments and cohesive clusters of primitive tumor cells with scant cytoplasm, ovoid nuclei with coarse granular chromatin, and consistently conspicuous single nucleoli in a frequently neutrophil-rich necrotic background with dispersed bare tumor nuclei. In fluid cytology, tight, 3-dimensional tumor clusters and singly lying tumor cells were observed. Squamous differentiation in the form of sheets and singly lying polygonal tumor cells with abundant dense cytoplasm was noted focally in rare cases. The diagnoses during original sign-outs were poorly differentiated carcinoma, poorly differentiated squamous cell carcinoma, and malignant small round cell tumor. NUT-1 (NUT family member 1 protein) immunocytochemistry performed on cell blocks demonstrated characteristic speckled nuclear staining in tumor cells. Pulmonary NC presents as a poorly differentiated carcinoma with focal to absent squamous differentiation on cytology. Cellular fragments of primitive tumor cells with conspicuous nucleoli should raise suspicion of NUT carcinoma and prompt ancillary testing.

Sections du résumé

BACKGROUND
NUT carcinoma (NC) is an aggressive neoplasm that often presents with alarge tumor burden and metastases; cytology is frequently one of the primary diagnostic modalities. Primary pulmonary NCs are very rare and cytology descriptions are limited. The current study was performed to analyze the cytomorphological features of primary pulmonary NCs in different cytology samples and preparations.
METHODS
A total of 15 cytology specimens from 10 patients with primary pulmonary NCs diagnosed primarily on histology were retrieved and reviewed.
RESULTS
Fifteen cytology samples, including aspirates from primary (5 samples) and metastatic (5 samples) sites, sputum (1 sample), and effusions (4 samples), that were prepared as direct smears, centrifuged smears, and cell blocks were reviewed. Aspirate smears from all cases were cellular and demonstrated fragments and cohesive clusters of primitive tumor cells with scant cytoplasm, ovoid nuclei with coarse granular chromatin, and consistently conspicuous single nucleoli in a frequently neutrophil-rich necrotic background with dispersed bare tumor nuclei. In fluid cytology, tight, 3-dimensional tumor clusters and singly lying tumor cells were observed. Squamous differentiation in the form of sheets and singly lying polygonal tumor cells with abundant dense cytoplasm was noted focally in rare cases. The diagnoses during original sign-outs were poorly differentiated carcinoma, poorly differentiated squamous cell carcinoma, and malignant small round cell tumor. NUT-1 (NUT family member 1 protein) immunocytochemistry performed on cell blocks demonstrated characteristic speckled nuclear staining in tumor cells.
CONCLUSIONS
Pulmonary NC presents as a poorly differentiated carcinoma with focal to absent squamous differentiation on cytology. Cellular fragments of primitive tumor cells with conspicuous nucleoli should raise suspicion of NUT carcinoma and prompt ancillary testing.

Identifiants

pubmed: 32877005
doi: 10.1002/cncy.22342
doi:

Substances chimiques

BRD3 protein, human 0
BRD4 protein, human 0
Cell Cycle Proteins 0
NUTM1 protein, human 0
Neoplasm Proteins 0
Nuclear Proteins 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-61

Informations de copyright

© 2020 American Cancer Society.

Références

Chirieac LR, French CA, Sholl L, Yatabi Y. Lung: other and unclassified carcinomas. In: Travis WD, Brambila E, Burke AP, Marx A, Nicholson AG, eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. International Agency for Research on Cancer; 2015:97-98.
Chau NG, Ma C, Danga K, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2019;4:pkz094. doi:10.1093/jncics/pkz094
Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18:5773-5779.
Kakkar A, Antony VM, Irugu DVK, Adhikari N, Jain D. NUT midline carcinoma: a series of five cases, including one with unusual clinical course. Head Neck Pathol. 2018;12:230-236.
French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304-307.
French CA, Ramirez CL, Kolmakova J, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27:2237-2242.
French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4:928-941.
Alekseyenko AA, Walsh EM, Zee BM, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114:E4184-E4192.
Grayson AR, Walsh EM, Cameron MJ, et al. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2014;33:1736-1742.
Stathis A, Zucca E, Bekradda M, et al. Clinical response of carcinomas harboring the BRD4-NUT oncoprotein to the targeted bromodomain inhibitor OTX015/MK-8628. Cancer Discov. 2016;6:492-500.
Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984-991.
Sholl LM, Nishino M, Pokharel S, et al. Primary pulmonary NUT midline carcinoma: clinical, radiographic, and pathologic characterizations. J Thorac Oncol. 2015;10:951-959.
Tanaka M, Kato K, Gomi K, et al. NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin. Am J Surg Pathol. 2012;36:381-388.
Watanabe S, Hirano S, Mine S, et al. A case of endobronchial NUT midline carcinoma with intraluminal growth. Anticancer Res. 2015;35:1607-1612.
Policarpio-Nicolas ML, De Leon EM, Jagirdar J. Cytologic findings of NUT midline carcinoma in the hilum of the lung. Diagn Cytopathol. 2015;43:739-742.
Kuroda S, Suzuki S, Kurita A, et al. Cytological features of a variant NUT midline carcinoma of the lung harboring the NSD3-NUT fusion gene: a case report and literature review. Case Rep Pathol. 2015;2015:572951. doi:10.1155/2015/572951
Bishop JA, French CA, Ali SZ. Cytopathologic features of NUT midline carcinoma: a series of 26 specimens from 13 patients. Cancer Cytopathol. 2016;124:901-918.
Zhu B, Laskin W, Chen Y, et al. NUT midline carcinoma: a neoplasm with diagnostic challenges in cytology. Cytopathology. 2011;22:414-417.
Santis G, Landau D, Harrison-Phipps K, Neat M, Moonim MT. Successful radical treatment of midline carcinoma with t(15;19) diagnosed by endobronchial ultrasound-derived transbronchial needle aspiration. J Clin Oncol. 2011;29:e327-e329.
Lee T, Choi S, Han J, Choi YL, Lee K. Abrupt dyskeratotic and squamoid cells in poorly differentiated carcinoma: case study of two thoracic NUT midline carcinomas with cytohistologic correlation. J Pathol Transl Med. 2018;52:349-353.
Shenoy KD, Stanzione N, Caron JE, et al. Midline carcinoma expressing NUT in malignant effusion cytology. Diagn Cytopathol. 2019;47:594-598.
Harms A, Herpel E, Pfarr N, et al. NUT carcinoma of the thorax: case report and review of the literature. Lung Cancer. 2015;90:484-491.
Puliyel MM, Mascarenhas L, Zhou S, et al. Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma. J Clin Oncol. 2014;32:e57-e60.
Ueki H, Maeda N, Sekimizu M, Yamashita Y, Moritani S, Horibe K. A case of NUT midline carcinoma with complete response to gemcitabine following cisplatin and docetaxel. J Pediatr Hematol Oncol. 2014;36:e476-e480.
Karakus E, Poyraz A, Oguz Erdogan AS, Emir S, Ozyoruk D. NUT midline carcinoma of the lung in a six-year-old child. Fetal Pediatr Pathol. 2017;36:472-474.
Cao J, Chen D, Yang F, Yao J, Zhu W, Zhao C. NUT midline carcinoma as a primary lung tumor: a case report. J Thorac Dis. 2017;9:E1045-E1049.
Baras AS, Naidoo J, Hann CL, Illei PB, Reninger CW, Lauring J. Rediagnosis of lung cancer as NUT midline carcinoma based on clues from tumor genomic profiling. J Natl Compr Canc Netw. 2018;16:467-472.
Pelosi G, Cannone M, Balladore E, et al. Spindle cell nuclear in testis carcinoma of the lung: a challenging tumor. J Thorac Oncol. 2019;14:311-313.
Zhou L, Yong X, Zhou J, Xu J, Wang C. Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingiva. Biomed Res Int. 2020;2020:9791208. doi:10.1155/2020/9791208
Keymel S, Kruger S. Lung cancer with prominent mediastinal lymphadenopathy-who thinks of NUT carcinoma [in German]? Pneumologie. 2020;74:35-38.

Auteurs

Rimlee Dutta (R)

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Aruna Nambirajan (A)

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Saurabh Mittal (S)

Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India.

Sinchita Roy-Chowdhuri (S)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Deepali Jain (D)

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH